DENALI THERAPEUTICS INC (DNLI) Institutional Shareholders

DENALI THERAPEUTICS INC (DNLI) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.63B in DNLI holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of DNLI tracked by InsiderSet, reporting ownership valued at approximately $250.26M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $300.05M, representing an estimated gain of +19.90% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 50% of the total disclosed DNLI value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Baillie Gifford & Co, Temasek Holdings (Private) Ltd, and several other long-term asset managers with concentrated positions in DENALI THERAPEUTICS INC (DNLI).

This page ranks the largest institutional DNLI shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

270

Total Reported Value

$2.63B

Largest Holder

Blackrock, Inc.

Largest Position

$250.26M

Insider Transactions (90d)

8

Latest Filing Quarter

Q2 2026

New Institutional Positions

104

Funds Exiting Positions

0

Page 1 of 6
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%13,034,115$250,255,006$300,045,327+$49,790,321+19.90%
Baillie Gifford & Co0.24%12,066,479$231,676,397$277,770,347+$46,093,950+19.90%
Temasek Holdings (Private) Ltd0.45%7,012,974$134,649,101$161,438,661+$26,789,560+19.90%
State Street Corp0.00%6,272,001$120,422,419$144,381,463+$23,959,044+19.90%
Vanguard Capital Management Llc0.00%6,147,957$118,040,774$141,525,970+$23,485,196+19.90%
Vanguard Portfolio Management Llc0.01%6,120,160$117,507,072$140,886,083+$23,379,011+19.90%
Fmr Llc0.00%4,575,374$87,847,187$105,325,109+$17,477,922+19.90%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.02%4,432,314$85,100,430$102,031,868+$16,931,438+19.90%
Goldman Sachs Group Inc0.01%4,407,255$84,619,301$101,455,010+$16,835,709+19.90%
Pictet Asset Management Holding Sa0.07%2,791,206$71,894,854$64,253,562-$7,641,292-10.63%
Baker Bros. Advisors Lp0.41%3,731,695$71,648,544$85,903,619+$14,255,075+19.90%
Geode Capital Management, Llc0.00%3,727,114$71,575,052$85,798,164+$14,223,112+19.87%
Holocene Advisors, Lp0.15%3,195,429$61,352,237$73,558,776+$12,206,539+19.90%
Dimensional Fund Advisors Lp0.01%2,692,175$51,686,812$61,973,869+$10,287,057+19.90%
Ubs Group Ag0.01%2,571,344$49,369,805$59,192,339+$9,822,534+19.90%
Capital Research Global Investors0.01%2,514,588$48,280,090$57,885,816+$9,605,726+19.90%
Alliancebernstein L.P.0.02%2,893,618$47,773,633$66,611,086+$18,837,453+39.43%
Fisher Asset Management, Llc0.02%2,436,895$46,788,383$56,097,323+$9,308,940+19.90%
Crestline Management, L.P.91.74%2,210,732$42,446,054$50,891,051+$8,444,997+19.90%
Alyeska Investment Group, L.P.0.11%1,941,123$37,269,562$44,684,651+$7,415,089+19.90%
Lynx1 Capital Management Lp5.71%1,880,303$36,101,818$43,284,575+$7,182,757+19.90%
Adar1 Capital Management, Llc2.16%1,871,455$35,931,936$43,080,894+$7,148,958+19.90%
Casdin Capital, Llc2.68%1,840,000$35,328,000$42,356,800+$7,028,800+19.90%
Aberdeen Group Plc0.05%1,345,481$34,605,771$30,972,973-$3,632,798-10.50%
Vestal Point Capital, Lp0.95%1,773,326$34,047,859$40,821,965+$6,774,106+19.90%
Principal Financial Group Inc0.02%1,478,486$28,386,931$34,034,748+$5,647,817+19.90%
Siren, L.L.C.0.74%1,396,513$26,813,050$32,147,729+$5,334,679+19.90%
Defilade Capital Management, L.P.3.67%1,359,969$26,111,405$31,306,486+$5,195,081+19.90%
Northern Trust Corp0.00%1,310,656$25,164,596$30,171,301+$5,006,705+19.90%
Millennium Management Llc0.02%1,257,950$24,152,640$28,958,009+$4,805,369+19.90%
Foresite Capital Management Vi Llc5.05%1,209,971$23,231,443$27,853,532+$4,622,089+19.90%
Charles Schwab Investment Management Inc0.00%1,207,399$23,182,061$27,794,325+$4,612,264+19.90%
Bank Of America Corp0.00%1,134,183$21,776,313$26,108,893+$4,332,580+19.90%
Morgan Stanley0.00%1,104,757$21,211,369$25,431,506+$4,220,137+19.90%
Candriam S.C.A.0.11%1,099,845$21,117,024$25,318,432+$4,201,408+19.90%
Artisan Partners Limited Partnership0.03%1,099,719$21,114,605$25,315,531+$4,200,926+19.90%
Marshall Wace, Llp0.02%991,268$19,032,346$22,818,989+$3,786,643+19.90%
Vanguard Fiduciary Trust Co0.00%949,695$18,234,144$21,861,979+$3,627,835+19.90%
American Century Companies Inc0.01%935,692$17,965,414$21,539,630+$3,574,216+19.89%
Bank Of New York Mellon Corp0.00%768,039$14,746,343$17,680,258+$2,933,915+19.90%
Clearstead Advisors, Llc0.13%737,990$14,169,408$16,988,530+$2,819,122+19.90%
Cercano Management Llc0.52%625,000$12,000,000$14,387,500+$2,387,500+19.90%
Masters Capital Management Llc1.70%600,000$11,520,000$13,812,000+$2,292,000+19.90%
Segall Bryant & Hamill, Llc0.18%519,600$11,228,555$11,961,192+$732,637+6.52%
Ensign Peak Advisors, Inc0.02%515,721$9,901,843$11,871,897+$1,970,054+19.90%
Stempoint Capital Lp1.60%426,561$8,189,971$9,819,434+$1,629,463+19.90%
Woodline Partners Lp0.03%364,082$6,990,374$8,381,168+$1,390,794+19.90%
Hudson Bay Capital Management Lp0.04%346,360$6,650,112$7,973,207+$1,323,095+19.90%
Dafna Capital Management Llc1.39%318,500$6,115,200$7,331,870+$1,216,670+19.90%
Invesco Ltd.0.00%310,196$5,955,763$7,140,712+$1,184,949+19.90%

Frequently asked questions about DNLI

  • Who owns the most DNLI stock?

    The largest holders of DNLI are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for DENALI THERAPEUTICS INC (DNLI).

  • Is DNLI widely held by superinvestors?

    Many widely followed stocks like DNLI appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly DNLI is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.